Bookmark?Remove?
Endo pulls opioid as U.S. seeks to tackle abuse epidemic
Endo International Plc said on Thursday it agreed to withdraw its long-acting opioid painkiller Opana ER from the market after the U.S. Food and Drug Administration declared its benefit did not outweigh public health risks associated with opioid abuse. More »
